Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Onn

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Respiratory Medicine|February 24, 2001
Eosinophil influx into the airways in patients with exercise-induced asthmaS Kivity, A Argaman, A Onn, et al.
Cancer Management and Research|May 23, 2019
L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patientsD Portal, L Hofstetter, I Eshed, et al.
Oncogene|April 28, 2015
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumorsS Carvalho, M Lindzen, M Lauriola, et al.
Bone Marrow Transplantation|May 8, 2007
Outcome of alveolar hemorrhage in hematopoietic stem cell transplant recipientsS Gupta, A Jain, C L Warneke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2015
Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trialJ Rodon, J C Soria, R Berger, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Respiratory Medicine|February 24, 2001
Eosinophil influx into the airways in patients with exercise-induced asthmaS Kivity, A Argaman, A Onn, et al.
Cancer Management and Research|May 23, 2019
L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patientsD Portal, L Hofstetter, I Eshed, et al.
Oncogene|April 28, 2015
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumorsS Carvalho, M Lindzen, M Lauriola, et al.
Bone Marrow Transplantation|May 8, 2007
Outcome of alveolar hemorrhage in hematopoietic stem cell transplant recipientsS Gupta, A Jain, C L Warneke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2015
Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trialJ Rodon, J C Soria, R Berger, et al.
Pageof 2